These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33724509)

  • 1. Epigenetic editing: Dissecting chromatin function in context.
    Policarpi C; Dabin J; Hackett JA
    Bioessays; 2021 May; 43(5):e2000316. PubMed ID: 33724509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas mediated epigenome editing for cancer therapy.
    Ansari I; Chaturvedi A; Chitkara D; Singh S
    Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 in epigenetics studies of health and disease.
    Sar P; Dalai S
    Prog Mol Biol Transl Sci; 2021; 181():309-343. PubMed ID: 34127198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility.
    Goell JH; Hilton IB
    Trends Biotechnol; 2021 Jul; 39(7):678-691. PubMed ID: 33972106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
    Maroufi F; Maali A; Abdollahpour-Alitappeh M; Ahmadi MH; Azad M
    Epigenomics; 2020 Oct; 12(20):1845-1859. PubMed ID: 33185489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editing the Epigenome: Reshaping the Genomic Landscape.
    Holtzman L; Gersbach CA
    Annu Rev Genomics Hum Genet; 2018 Aug; 19():43-71. PubMed ID: 29852072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
    Lau CH; Suh Y
    Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precise epigenomic editing with a SunTag-based modular epigenetic toolkit.
    Guhathakurta S; Adams L; Jeong I; Sivakumar A; Cha M; Bernardo Fiadeiro M; Hu HN; Kim YS
    Epigenetics; 2022 Dec; 17(13):2075-2081. PubMed ID: 35920441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression.
    Seem K; Kaur S; Kumar S; Mohapatra T
    Crit Rev Biochem Mol Biol; 2024; 59(1-2):69-98. PubMed ID: 38440883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing the Epigenome to Tackle Brain Disorders.
    Liu XS; Jaenisch R
    Trends Neurosci; 2019 Dec; 42(12):861-870. PubMed ID: 31706628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing CRISPR-Cas9 for Epigenetic Engineering.
    Guerra-Resendez RS; Hilton IB
    Methods Mol Biol; 2022; 2518():237-251. PubMed ID: 35666449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-Tuning the Epigenetic Landscape: Chemical Modulation of Epigenome Editors.
    Noviello G; Gjaltema RAF
    Methods Mol Biol; 2024; 2842():57-77. PubMed ID: 39012590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
    Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
    Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases.
    Singh DD; Hawkins RD; Lahesmaa R; Tripathi SK
    Semin Cell Dev Biol; 2019 Dec; 96():32-43. PubMed ID: 31112800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reader-Effectors as Actuators of Epigenome Editing.
    Kim SH; Haynes KA
    Methods Mol Biol; 2024; 2842():103-127. PubMed ID: 39012592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances of epigenetic editing.
    Gjaltema RAF; Rots MG
    Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing.
    O'Geen H; Tomkova M; Combs JA; Tilley EK; Segal DJ
    Nucleic Acids Res; 2022 Apr; 50(6):3239-3253. PubMed ID: 35234927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editing of DNA Methylation Patterns Using CRISPR-Based Tools.
    Smith J; Banerjee R; Weeks RJ; Chatterjee A
    Methods Mol Biol; 2022; 2458():63-74. PubMed ID: 35103962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.